Neuropsychiatric and Cognitive Safety of Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease: Insights From a Real-World Cohort

Journal of Movement Disorders · Published 2026-01-25 · DOI 10.14802/jmd.25304

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.14802/jmd.25304

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles